Synaptic dysfunction in schizophrenia

Synapse. 2023 Sep;77(5):e22276. doi: 10.1002/syn.22276. Epub 2023 May 21.

Abstract

Schizophrenia is a chronic disease presented with psychotic symptoms, negative symptoms, impairment in the reward system, and widespread neurocognitive deterioration. Disruption of synaptic connections in neural circuits is responsible for the disease's development and progression. Because deterioration in synaptic connections results in the impaired effective processing of information. Although structural impairments of the synapse, such as a decrease in dendritic spine density, have been shown in previous studies, functional impairments have also been revealed with the development of genetic and molecular analysis methods. In addition to abnormalities in protein complexes regulating exocytosis in the presynaptic region and impaired vesicle release, especially, changes in proteins related to postsynaptic signaling have been reported. In particular, impairments in postsynaptic density elements, glutamate receptors, and ion channels have been shown. At the same time, effects on cellular adhesion molecular structures such as neurexin, neuroligin, and cadherin family proteins were detected. Of course, the confusing effect of antipsychotic use in schizophrenia research should also be considered. Although antipsychotics have positive and negative effects on synapses, studies indicate synaptic deterioration in schizophrenia independent of drug use. In this review, the deterioration in synapse structure and function and the effects of antipsychotics on the synapse in schizophrenia will be discussed.

Keywords: antipsychotics; dendritic spine; postsynaptic density; synapse; vesicle proteins.

Publication types

  • Review

MeSH terms

  • Antipsychotic Agents*
  • Humans
  • Schizophrenia* / drug therapy
  • Schizophrenia* / metabolism
  • Signal Transduction
  • Synapses / metabolism

Substances

  • Antipsychotic Agents